EO2(EPA:ALEO2) stock Fundamental Analysis

Fundamental Rating

ALEO2 gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 63 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of ALEO2 is average, but there are quite some concerns on its profitability. ALEO2 does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALEO2 had positive earnings in the past year.

ALEO2 had a negative operating cash flow in the past year.

Each year in the past 5 years ALEO2 has been profitable.

ALEO2 had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ALEO2 has a worse Return On Assets (1.60%) than 74.60% of its industry peers.

ALEO2 has a worse Return On Equity (3.48%) than 76.19% of its industry peers.

ALEO2 has a Return On Invested Capital of 0.74%. This is amonst the worse of the industry: ALEO2 underperforms 80.95% of its industry peers.

The Average Return On Invested Capital over the past 3 years for ALEO2 is significantly below the industry average of 12.53%.

		Industry Rank	Sector Rank
ROA	1.6%
ROE	3.48%
ROIC	0.74%

ROA(3y)4.32%

ROA(5y)3.34%

ROE(3y)9.77%

ROE(5y)7.71%

ROIC(3y)4.43%

ROIC(5y)3.25%

1.3 Margins

ALEO2 has a Profit Margin of 2.08%. This is in the lower half of the industry: ALEO2 underperforms 76.19% of its industry peers.

ALEO2's Profit Margin has declined in the last couple of years.

With a Operating Margin value of 1.19%, ALEO2 is not doing good in the industry: 80.95% of the companies in the same industry are doing better.

ALEO2's Operating Margin has declined in the last couple of years.

ALEO2's Gross Margin of 42.46% is in line compared to the rest of the industry. ALEO2 outperforms 50.79% of its industry peers.

ALEO2's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	1.19%
PM (TTM)	2.08%
GM	42.46%

OM growth 3Y-4.51%

OM growth 5Y-16.63%

PM growth 3Y23.02%

PM growth 5Y-5.38%

GM growth 3Y25.04%

GM growth 5Y9.23%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALEO2 is destroying value.

Compared to 1 year ago, ALEO2 has less shares outstanding

The number of shares outstanding for ALEO2 has been reduced compared to 5 years ago.

ALEO2 has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.78, we must say that ALEO2 is in the distress zone and has some risk of bankruptcy.

ALEO2 has a Altman-Z score of 1.78. This is comparable to the rest of the industry: ALEO2 outperforms 50.79% of its industry peers.

A Debt/Equity ratio of 0.50 indicates that ALEO2 is not too dependend on debt financing.

ALEO2 has a Debt to Equity ratio of 0.50. This is comparable to the rest of the industry: ALEO2 outperforms 50.79% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	N/A
Altman-Z	1.78

ROIC/WACC0.12

WACC6.03%

2.3 Liquidity

A Current Ratio of 2.59 indicates that ALEO2 has no problem at all paying its short term obligations.

ALEO2 has a Current ratio of 2.59. This is amongst the best in the industry. ALEO2 outperforms 80.95% of its industry peers.

ALEO2 has a Quick Ratio of 1.80. This is a normal value and indicates that ALEO2 is financially healthy and should not expect problems in meeting its short term obligations.

ALEO2 has a better Quick ratio (1.80) than 77.78% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.59
Quick Ratio	1.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALEO2 have decreased strongly by -96.09% in the last year.

The Earnings Per Share has been growing slightly by 0.52% on average over the past years.

The Revenue for ALEO2 has decreased by -31.55% in the past year. This is quite bad

ALEO2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.99% yearly.

EPS 1Y (TTM)-96.09%

EPS 3Y35.45%

EPS 5Y0.52%

EPS Q2Q%-58.53%

Revenue 1Y (TTM)-31.55%

Revenue growth 3Y11.24%

Revenue growth 5Y5.99%

Sales Q2Q%-17.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 49.86, which means the current valuation is very expensive for ALEO2.

ALEO2's Price/Earnings ratio is a bit more expensive when compared to the industry. ALEO2 is more expensive than 79.37% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 29.35. ALEO2 is valued rather expensively when compared to this.

		Industry Rank	Sector Rank
PE	49.86
Fwd PE	N/A

4.2 Price Multiples

ALEO2's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	6.17

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)95.04

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALEO2!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EO2

EPA:ALEO2 (3/7/2025, 7:00:00 PM)

3.49

-0.06 (-1.69%)

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap8.38M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.14

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	49.86
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	0.41
P/tB	0.45
EV/EBITDA	6.17

EPS(TTM)0.07

EY2.01%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-2.82

FCFYN/A

OCF(TTM)-1.1

OCFYN/A

SpS14.2

BVpS8.5

TBVpS7.82

PEG (NY)N/A

PEG (5Y)95.04

Profitability

		Industry Rank	Sector Rank
ROA	1.6%
ROE	3.48%
ROCE	1.14%
ROIC	0.74%
ROICexc	0.93%
ROICexgc	0.98%
OM	1.19%
PM (TTM)	2.08%
GM	42.46%
FCFM	N/A

ROA(3y)4.32%

ROA(5y)3.34%

ROE(3y)9.77%

ROE(5y)7.71%

ROIC(3y)4.43%

ROIC(5y)3.25%

ROICexc(3y)7.15%

ROICexc(5y)5.22%

ROICexgc(3y)7.62%

ROICexgc(5y)5.52%

ROCE(3y)6.78%

ROCE(5y)4.98%

ROICexcg growth 3Y-0.06%

ROICexcg growth 5Y-15.64%

ROICexc growth 3Y-0.72%

ROICexc growth 5Y-16.61%

OM growth 3Y-4.51%

OM growth 5Y-16.63%

PM growth 3Y23.02%

PM growth 5Y-5.38%

GM growth 3Y25.04%

GM growth 5Y9.23%

F-Score3

Asset Turnover0.77

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	N/A
Debt/EBITDA	4.41
Cap/Depr	218.47%
Cap/Sales	12.12%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.59
Quick Ratio	1.8
Altman-Z	1.78

F-Score3

WACC6.03%

ROIC/WACC0.12

Cap/Depr(3y)123.02%

Cap/Depr(5y)99.34%

Cap/Sales(3y)7.35%

Cap/Sales(5y)6.3%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-96.09%

EPS 3Y35.45%

EPS 5Y0.52%

EPS Q2Q%-58.53%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-31.55%

Revenue growth 3Y11.24%

Revenue growth 5Y5.99%

Sales Q2Q%-17.61%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-93.7%

EBIT growth 3Y6.23%

EBIT growth 5Y-11.64%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-264.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-147.88%

OCF growth 3YN/A

OCF growth 5YN/A

EO2 (ALEO2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens